✦ LIBER ✦

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma

✍ Scribed by Anil Tulpule; Gary Schiller; Laura A. Harvey-Buchanan; Myung Lee; Byron M. Espina; Aziz U. Khan; William Boswell; Bharat Nathwani; Alexandra M. Levine

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 87 KB
Volume: 83
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19981201)83:11<2370::aid-cncr17>3.0.co;2-m

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Cladribine (2-chlorodeoxyadenosine) is a purine nucleoside analog with cytotoxic activity against both resting and proliferating cells. Clinical studies with cladribine have reported antitumor activity against various hematologic malignancies.

📜 SIMILAR VOLUMES

Value of radiation therapy in the manage

Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma

✍ Amr Aref; Samir Narayan; Samuel Tekyi-Mensah; Mary Varterasian; Maria Dan; David 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

The purpose of this study was to evaluate the probability and extent of response to radiation therapy in patients with chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma. Thirty-five patients with chemotherapy-resistant non-Hodgkin's lymphoma received local radiation therapy after init

A phase II trial of teniposide (VM 26) i

A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients

✍ Dr. Umberto Tirelli; Antonino Carbone; Diana Crivellari; Rachele Volpe; Giovanni 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB